InMed Pharmaceuticals Inc (INM)

InMed Pharmaceuticals Inc (INM) 最新ニュース

InMed Pharmaceuticals (OTCMKTS:IMLFF) Shares Pass Below 50-Day Moving Average of $0.32 - Defense World

Defense World

InMed (INM) Gets Grant to Begin Neurodegenerative Diseases Program - Yahoo News UK

Yahoo News UK

InMed Pharmaceuticals Excels in Q3 with Promising Trials - TipRanks.com - TipRanks

TipRanks

InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's ... - Nasdaq

Nasdaq

InMed Pharmaceuticals (TSE:IN) Shares Down 1.6% - Defense World

Defense World

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's - Benzinga

Benzinga

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's - Benzinga

Benzinga

Glaucoma Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies ... - openPR

openPR

InMed Pharmaceuticals Welcomes Alzheimer's Expert - TipRanks.com - TipRanks

TipRanks

InMed appoints neurodegenerative expert to advisory board By Investing.com - Investing.com

Investing.com

InMed Pharmaceuticals Inc (INM) Stock Closes down -4.16% Tuesday's – DWinneX - The Dwinnex

The Dwinnex

InMed Pharmaceuticals Inc (INM) Stock Closes down -4.16% Tuesday's – DWinneX - The Dwinnex

The Dwinnex

InMed's INM-089 Shows Promise for AMD Treatment - TipRanks.com - TipRanks

TipRanks

InMed reports progress in Alzheimer's treatment studies By Investing.com - Investing.com

Investing.com

InMed Pharmaceuticals Granted Nasdaq Compliance Extension - TipRanks.com - TipRanks

TipRanks

InMed Pharmaceuticals gets extended Nasdaq compliance period - Investing.com India

Investing.com India

InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

Benzinga

Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying

Benzinga

Netta Jagpal Named InMed Pharmaceuticals CFO - CEOWORLD magazine

CEOWORLD magazine

InMed Pharmaceuticals Welcomes New CFO Neeta Jagpal - TipRanks.com - TipRanks

TipRanks

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Benzinga

Investment Chief At $48B Global X Forecasts AI Stock Dominance In 2024: Unveils Top Investment Opportunities

Benzinga

Inmed's INM-089 improves retinal function in in vivo preclinical AMD disease model - BioWorld Online

BioWorld Online

InMed (NASDAQ: INM) up 300% - then guess what? A stock issue, that’s what - Dhaka Tribune

Dhaka Tribune

InMed Pharmaceuticals Inc.'s INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in ... - Yahoo Finance

Yahoo Finance

Cardiometabolic Drugs Market revenue to exceed USD 72 Billion by 2035, says Research Nester - GlobeNewswire

GlobeNewswire

Zynerbia Pharmaceuticals Inc. (NASDAQ: ZYNE), MedMen Enterprises Inc. (OTCMKTS: MMNFF), 1933 Industries Inc ... - FactsAboutCBD

FactsAboutCBD

InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare ... - GlobeNewswire

GlobeNewswire

InMed, Almac Improving Cannabinoid Production Methods - Contract Pharma

Contract Pharma

NetworkNewsWire Announces Publication Highlighting Big Pharma's Appetite for M&A Possibilities in Cannabis - Yahoo Lifestyle UK

Yahoo Lifestyle UK

InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs - Canada NewsWire

Canada NewsWire